Trexquant Investment’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
483,400
+354,221
| +274% | +$3.13M | 0.05% | 593 |
|
|
2025
Q1 | $1.01M | Buy |
+129,179
| New | +$1.01M | 0.01% | 1088 |
|
|
2024
Q4 | – | Sell |
-44,811
| Closed | -$588K | – | 1543 |
|
|
2024
Q3 | $588K | Buy |
+44,811
| New | +$588K | 0.01% | 1213 |
|
|
2023
Q2 | – | Sell |
-42,435
| Closed | -$389K | – | 1426 |
|
|
2023
Q1 | $389K | Buy |
+42,435
| New | +$389K | 0.01% | 1094 |
|
|
2022
Q1 | – | Sell |
-23,500
| Closed | -$190K | – | 1344 |
|
|
2021
Q4 | $190K | Buy |
+23,500
| New | +$190K | 0.01% | 1161 |
|
|
2018
Q3 | – | Sell |
-10,839
| Closed | -$66K | – | 942 |
|
|
2018
Q2 | $66K | Sell |
10,839
-34,567
| -76% | -$210K | ﹤0.01% | 852 |
|
|
2018
Q1 | $331K | Buy |
45,406
+31,030
| +216% | +$226K | 0.02% | 781 |
|
|
2017
Q4 | $118K | Sell |
14,376
-21,842
| -60% | -$179K | 0.01% | 997 |
|
|
2017
Q3 | $380K | Buy |
36,218
+5,718
| +19% | +$60K | 0.1% | 375 |
|
|
2017
Q2 | $336K | Buy |
30,500
+7,169
| +31% | +$79K | 0.09% | 405 |
|
|
2017
Q1 | $226K | Buy |
23,331
+11,031
| +90% | +$107K | 0.03% | 905 |
|
|
2016
Q4 | $128K | Buy |
+12,300
| New | +$128K | 0.02% | 890 |
|
|
2016
Q2 | – | Sell |
-105,369
| Closed | -$1.16M | – | 865 |
|
|
2016
Q1 | $1.16M | Buy |
+105,369
| New | +$1.16M | 0.14% | 245 |
|
|
2015
Q4 | – | Sell |
-60,100
| Closed | -$980K | – | 1001 |
|
|
2015
Q3 | $980K | Buy |
60,100
+44,430
| +284% | +$724K | 0.08% | 423 |
|
|
2015
Q2 | $332K | Sell |
15,670
-36,630
| -70% | -$776K | 0.04% | 778 |
|
|
2015
Q1 | $940K | Buy |
52,300
+32,100
| +159% | +$577K | 0.1% | 395 |
|
|
2014
Q4 | $346K | Buy |
+20,200
| New | +$346K | 0.06% | 622 |
|